ZA9810357B - Use of ketolides for the preparation of pharmaceutical compositions intended to prevent arterial thrombotic complications linked with atherosclerosis. - Google Patents

Use of ketolides for the preparation of pharmaceutical compositions intended to prevent arterial thrombotic complications linked with atherosclerosis.

Info

Publication number
ZA9810357B
ZA9810357B ZA9810357A ZA9810357A ZA9810357B ZA 9810357 B ZA9810357 B ZA 9810357B ZA 9810357 A ZA9810357 A ZA 9810357A ZA 9810357 A ZA9810357 A ZA 9810357A ZA 9810357 B ZA9810357 B ZA 9810357B
Authority
ZA
South Africa
Prior art keywords
ketolides
atherosclerosis
preparation
pharmaceutical compositions
compositions intended
Prior art date
Application number
ZA9810357A
Other languages
English (en)
Inventor
Francis Petit
Francoise Vacheron
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ZA9810357B publication Critical patent/ZA9810357B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA9810357A 1997-11-17 1998-11-12 Use of ketolides for the preparation of pharmaceutical compositions intended to prevent arterial thrombotic complications linked with atherosclerosis. ZA9810357B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (1)

Publication Number Publication Date
ZA9810357B true ZA9810357B (en) 1999-11-12

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810357A ZA9810357B (en) 1997-11-17 1998-11-12 Use of ketolides for the preparation of pharmaceutical compositions intended to prevent arterial thrombotic complications linked with atherosclerosis.

Country Status (35)

Country Link
US (1) US20080139489A1 (es)
EP (1) EP1030673B1 (es)
JP (1) JP4550273B2 (es)
KR (1) KR20010032130A (es)
CN (1) CN1286633A (es)
AP (1) AP1196A (es)
AR (1) AR014119A1 (es)
AT (1) ATE271875T1 (es)
AU (1) AU744419B2 (es)
BG (1) BG104427A (es)
BR (1) BR9814199A (es)
CA (1) CA2312021C (es)
DE (1) DE69825308T2 (es)
DZ (1) DZ2654A1 (es)
EA (1) EA003322B1 (es)
EE (1) EE04095B1 (es)
ES (1) ES2224446T3 (es)
FR (1) FR2771008B1 (es)
GE (1) GEP20032968B (es)
HR (1) HRP20000314A2 (es)
HU (1) HUP0004507A3 (es)
ID (1) ID24940A (es)
IL (1) IL136149A0 (es)
MA (1) MA26566A1 (es)
NO (1) NO20002435L (es)
NZ (1) NZ504305A (es)
OA (1) OA11411A (es)
PL (1) PL340373A1 (es)
SK (1) SK7042000A3 (es)
TN (1) TNSN98206A1 (es)
TR (1) TR200001384T2 (es)
TW (1) TW472061B (es)
WO (1) WO1999025365A1 (es)
YU (1) YU29600A (es)
ZA (1) ZA9810357B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
WO2000034297A1 (en) * 1998-12-10 2000-06-15 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
ATE256694T1 (de) * 1999-01-27 2004-01-15 Pfizer Prod Inc Ketolid-antibiotika
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
CZ20023290A3 (cs) 2000-04-04 2003-03-12 Smithkline Beecham Plc 2-Hydroxymutilinkarbamátové deriváty pro antibakteriální použití
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
JP6042334B2 (ja) * 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
NO20002435D0 (no) 2000-05-11
AP1196A (en) 2003-08-18
AU1242599A (en) 1999-06-07
TW472061B (en) 2002-01-11
OA11411A (fr) 2004-04-20
NO20002435L (no) 2000-07-07
FR2771008B1 (fr) 2000-04-28
EA003322B1 (ru) 2003-04-24
MA26566A1 (fr) 2004-12-20
TNSN98206A1 (fr) 2005-03-15
DE69825308T2 (de) 2005-08-04
TR200001384T2 (tr) 2001-06-21
ID24940A (id) 2000-08-31
KR20010032130A (ko) 2001-04-16
HUP0004507A1 (hu) 2001-05-28
HUP0004507A3 (en) 2001-12-28
EE04095B1 (et) 2003-08-15
EP1030673A1 (fr) 2000-08-30
DE69825308D1 (de) 2004-09-02
EE200000244A (et) 2001-06-15
US20080139489A1 (en) 2008-06-12
GEP20032968B (en) 2003-05-27
IL136149A0 (en) 2001-05-20
YU29600A (sh) 2003-02-28
HRP20000314A2 (en) 2001-02-28
AU744419B2 (en) 2002-02-21
CN1286633A (zh) 2001-03-07
BR9814199A (pt) 2000-09-26
ES2224446T3 (es) 2005-03-01
NZ504305A (en) 2002-11-26
FR2771008A1 (fr) 1999-05-21
JP4550273B2 (ja) 2010-09-22
JP2001523644A (ja) 2001-11-27
PL340373A1 (en) 2001-01-29
CA2312021C (fr) 2008-08-26
DZ2654A1 (fr) 2003-03-22
WO1999025365A1 (fr) 1999-05-27
SK7042000A3 (en) 2000-12-11
CA2312021A1 (fr) 1999-05-27
EP1030673B1 (fr) 2004-07-28
EA200000531A1 (ru) 2000-10-30
ATE271875T1 (de) 2004-08-15
AP2000001825A0 (en) 2000-06-30
AR014119A1 (es) 2001-02-07
BG104427A (en) 2001-02-28

Similar Documents

Publication Publication Date Title
IL142865A0 (en) Methods and compositions for the prevention of tolerance to medications
HUP0004133A3 (en) Combined use of progestin and polycarboxilic acid for the preparation of pharmaceutical compositions for controlled bleeding
ZA991716B (en) Pharmaceutical composition of topiramate.
AU4027195A (en) Water-in-oil-in-water compositions
AU8175291A (en) Stabilized liquid fiber- and skin-treating compositions
ZA986532B (en) Benefit agent compositions comprising mixtures of alpha-hydroxy esters.
AU6190298A (en) Liquid antacid compositions
ZA9810357B (en) Use of ketolides for the preparation of pharmaceutical compositions intended to prevent arterial thrombotic complications linked with atherosclerosis.
AU6370299A (en) Pharmaceutical compositions containing tetrahydroisoquinoline compounds
AU3078395A (en) Phenylcarbamate derivatives suitable to the use as anticholinesterase substances
AU4244996A (en) Buffered emulsion compositions containing actives subject to acid or base hydrolysis
AU768217C (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
HUP9802005A3 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions for reducing the cardiotoxic effect of some substances
GB0029650D0 (en) Proces for the preparation of 1,1-cyclopropanedicarboxylic diesters
AU7031798A (en) Use of pivagabin to prepare pharmaceutical compositions
GB2321389B (en) Improvements to shelving
GB9827806D0 (en) Improvements relating primarily to sound & lighting mixing consoles
HUP0200547A3 (en) Methods for producing pharmaceutical compositions to potentiate intravenous estramustine phosphate
HUP0201321A3 (en) New betha-amide and betha-sulfonamide carboxylic acid derivatives, their preparation and pharmaceutical compositions containing the compounds
AU5874496A (en) The use of c16-c18alkylpolyglycosides as d efoamers in cleaning compositions
AU5852299A (en) Catalyst compositions and process for the preparation of polyketones
AU5550200A (en) Topical composition comprising acetyl salicylic acid
PL328312A1 (en) Natural pharmaceutic agent capable to activate the immunological system
ZA985837B (en) Process for the preparation of substituted anthraquinones and application to the preparation of rheins.
HUP9902851A3 (en) Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation